You are here: Industry Insights > GSK

News List

GSK gets EU go-ahead for triple therapy inhaler in COPD .pharmafile
November 17, 2017
The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema, it has emerged.
GSK Consumer Q2 profit up marginally at Rs 192 cr expressbpd
November 08, 2017
GlaxoSmithKline Consumer Healthcare (GSKCH) reported 4.73 per cent increase in net profit at Rs 192.41 crore for the second quarter ended September 30, 2017—18.
Witty to lead way in fast-tracking medicine through UK system pharmafile
November 06, 2017
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK CEO tasked to lead a panel in proposing a handful of drugs and devices to be sped through the system.
GSK’s R&D head to move on after shift in focus pharmafile
November 06, 2017
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from Andrew Witty, with the latest seeing its R&D head set to leave to become the UK government’s Chief Scientific Adviser.
GSK’s Anoro Ellipta beats BI’s Spiolto Respimat in COPD trial pharmatimes
November 03, 2017
GlaxoSmithKline and Innoviva say their combination lung therapy Anoro Ellipta has come out on top in a trial pitting its effectiveness in improving lung function against that of Boehringer Ingelheim’s Spiolto Respimat.
GSK eyes healthcare expansion, hits targets due to new drugs pharmafile
October 27, 2017
During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster its healthcare unit, even as other companies look to slim down.
GSK's 'bubble boy' gene therapy secures NICE recommendation despite high cost pharmafile
October 26, 2017
GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase deficiency or ‘bubble boy’ syndrome, has been given a positive recommendation by NICE despite the extremely high cost associated wi
Plasticell and GSK collaborate to produce hematopoietic cells from iPSCs pharmaasia
October 26, 2017
Plasticell will contribute its CombiCult®stem cell screening technology to optimise iPSC specification for GSK research use.
GSK's shingles vaccine scores US approval pharmafile
October 24, 2017
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
GSK and Plasticell to manufacture haematopoietic cells from iPSC pharmaceufical-technology
October 20, 2017
Plasticell is a biotechnology company that specialises in stem cell screening and the development of cell therapy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page